Organogenesis Holdings Inc.·4

Feb 18, 4:37 PM ET

Francisco David 4

Research Summary

AI-generated summary

Updated

Organogenesis (ORGO) CFO Francisco David Withholds 52,448 Shares

What Happened
CFO Francisco David surrendered/withheld a total of 52,448 ORGO shares on 2026-02-15 to satisfy tax liabilities and/or exercise-price obligations. The four withholding dispositions were at $3.73 per share (3,898; 21,412; 13,369; 13,769 shares), with line values of $14,540, $79,867, $49,866 and $51,358 respectively — about $195,631 in aggregate. These were tax/exercise-related withholdings (Form 4 code “F”), not open-market sales.

Key Details

  • Transaction date: 2026-02-15; Form 4 filed: 2026-02-18 (appears filed within required business-day window).
  • Price per share: $3.73; total shares withheld: 52,448; total value ≈ $195,631.
  • Line-item disposals: 3,898; 21,412; 13,369; 13,769 shares (see values above).
  • Transaction code: F = payment of exercise price or tax liability (withholding).
  • Shares owned after transaction: not specified in the provided filing excerpt.
  • No 10b5-1 plan or other special instructions disclosed in the provided details.

Context
This appears to be a routine tax-withholding/cashless step tied to option exercises or award vesting — common for executives and not a market sell signal. For retail investors, purchases or open-market buys are generally more indicative of bullish insider sentiment; withholdings to cover taxes are administrative and frequently occur after exercises or vesting events.